Show Search Form

Search Results

registered interest	true false
date	exactly: or between: and
answering body
answering dept id
answering dept short name
answering dept sort name
hansard heading
house id
legislature	pref label
question text
tabling member constituency
tabling member printed
uin
answer	is ministerial correction true false date of answer exactly: or between: and answer text answering member constituency answering member printed grouped question UIN question first answered answering member label
tabling member	label

Search

227296

registered interest
date	13/03/2015
answering body	Department of Health
answering dept id	17
answering dept short name	Health
answering dept sort name	Health
hansard heading	Department of Health: Off-payroll Working
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health, how many staff in his Department and its executive agencies and associated bodies were engaged off-payroll in each of the last five years up to the most recent period for which figures are available.
tabling member constituency	Airdrie and Shotts
tabling member printed	Pamela Nash
uin	227548
answer	answer is ministerial correction date of answer 20/03/2015 answer text <p>The number of staff (expressed as Full Time Equivalents: (FTE)) engaged ‘off payroll’ - defined as agency workers, contractors and consultants - by the Department and its executive agencies: the Medicines and Healthcare products Regulatory Agency (MHRA) and Public Health England (PHE) are given in the tables below.</p><p> </p><p><strong> </strong></p><p> </p><p>Figures for the Department</p><p> </p><table><tbody><tr><td><p>Financial Year</p></td><td><p>Total FTE</p></td></tr><tr><td><p>2010 - 11</p></td><td><p>507.1</p></td></tr><tr><td><p>2011 - 12</p></td><td><p>353.1</p></td></tr><tr><td><p>2012 - 13</p></td><td><p>399.5</p></td></tr><tr><td><p>2013 - 14</p></td><td><p>262.7</p></td></tr><tr><td><p>2014 – 15 to date</p></td><td><p>187.5</p></td></tr></tbody></table><p> </p><p> </p><p> </p><p>Figures for MHRA</p><p> </p><table><tbody><tr><td><p>Financial Year</p></td><td><p>Total FTE</p></td></tr><tr><td><p>2010 - 11</p></td><td><p>Nil</p></td></tr><tr><td><p>2011 - 12</p></td><td><p>Nil</p></td></tr><tr><td><p>2012 - 13</p></td><td><p>2.0</p></td></tr><tr><td><p>2013 - 14</p></td><td><p>3.0</p></td></tr><tr><td><p>2014 – 15 to date</p></td><td><p>2.7</p></td></tr></tbody></table><p> </p><p> </p><p> </p><p>Figures for PHE (Established 1 April 2013)</p><p> </p><table><tbody><tr><td><p>Financial Year</p></td><td><p>Total FTE</p></td></tr><tr><td><p>2013 - 14</p></td><td><p>490.9</p></td></tr><tr><td><p>2014 – 15 to date</p></td><td><p>283.7</p></td></tr></tbody></table><p> </p><p> </p><p> </p> answering member constituency Central Suffolk and North Ipswich answering member printed Dr Daniel Poulter question first answered 20/03/2015 13:46:12 answering member 3932 label Biography information for Dr Dan Poulter
tabling member	3909 label Biography information for Pamela Nash

227297

registered interest
date	13/03/2015
answering body	Department of Health
answering dept id	17
answering dept short name	Health
answering dept sort name	Health
hansard heading	Diabetes
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health, if he will take steps to implement the recommendations of Diabetes UK's report State of the Nation (England): Challenges for 2015 and beyond, published in January 2015.
tabling member constituency	Southend West
tabling member printed	Sir David Amess
uin	227503
answer	answer is ministerial correction date of answer 20/03/2015 answer text <p>Diabetes UK’s <em>State of the Nation</em> report called for good care for everyone with diabetes, and a greater focus on prevention. Over recent years, the quality of NHS services for people with diabetes has improved and, as a result, so have health and care outcomes.</p><p> </p><p> </p><p> </p><p>NHS England has prioritised the prevention of Type 2 diabetes. It has recently launched a programme which will make England the first country to implement at scale a national Type 2 diabetes prevention programme, modelled on our own and international proven experience. It will link into the NHS Health Check programme, which helps identify people between 40 and 75 at risk of diabetes early on so that action can be taken to prevent the disease from occurring. In the last year, almost 3 million NHS Health Check offers were made and almost 1.5 million appointments were taken up.</p><p> </p><p> </p><p> </p><p>Outcomes for people with diabetes are measured through the NHS Outcomes Framework and the Clinical Commissioning Group Outcomes Indicator Set, which are both updated and published annually. This provides clear, comparative information for clinical commissioning groups (CCGs), health and wellbeing boards, local authorities, patients and the public about the quality of health services commissioned by CCGs and the associated health outcomes. Reviewing progress against these indicators forms part of NHS England's on-going assurance of CCGs.</p><p> </p><p> </p><p> </p><p>In addition, Public Health England has produced <em>Healthier Lives: Diabetes</em>, an online tool with interactive heat maps demonstrating prevalence, complications, levels of care provided and the quality of care achieved for people with diabetes by local authority, clinical commissioning group and general practice. This allows local comparisons to be made against the England average as well different localities.</p><p> </p><p> </p><p> </p><p><em>Action for Diabetes</em> set out a broad vision and direction for how NHS England will support improvements in outcomes for people with and at risk of diabetes in the coming years, as a direct commissioner of services and supporting CCGs in their commissioning role. There were no recommendations specifically for CCGs to deliver.</p><p> </p> answering member constituency Battersea answering member printed Jane Ellison grouped question UIN 227501 227502 question first answered 20/03/2015 14:20:12 answering member 3918 label Biography information for Jane Ellison
tabling member	44 label Biography information for Sir David Amess

227298

registered interest
date	13/03/2015
answering body	Department of Health
answering dept id	17
answering dept short name	Health
answering dept sort name	Health
hansard heading	Diabetes
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health, what arrangements his Department has in place to monitor and assess the progress of local clinical commissioning groups in implementing the recommendations of NHS England's Action for Diabetes strategy.
tabling member constituency	Southend West
tabling member printed	Sir David Amess
uin	227501
answer	answer is ministerial correction date of answer 20/03/2015 answer text <p>Diabetes UK’s <em>State of the Nation</em> report called for good care for everyone with diabetes, and a greater focus on prevention. Over recent years, the quality of NHS services for people with diabetes has improved and, as a result, so have health and care outcomes.</p><p> </p><p> </p><p> </p><p>NHS England has prioritised the prevention of Type 2 diabetes. It has recently launched a programme which will make England the first country to implement at scale a national Type 2 diabetes prevention programme, modelled on our own and international proven experience. It will link into the NHS Health Check programme, which helps identify people between 40 and 75 at risk of diabetes early on so that action can be taken to prevent the disease from occurring. In the last year, almost 3 million NHS Health Check offers were made and almost 1.5 million appointments were taken up.</p><p> </p><p> </p><p> </p><p>Outcomes for people with diabetes are measured through the NHS Outcomes Framework and the Clinical Commissioning Group Outcomes Indicator Set, which are both updated and published annually. This provides clear, comparative information for clinical commissioning groups (CCGs), health and wellbeing boards, local authorities, patients and the public about the quality of health services commissioned by CCGs and the associated health outcomes. Reviewing progress against these indicators forms part of NHS England's on-going assurance of CCGs.</p><p> </p><p> </p><p> </p><p>In addition, Public Health England has produced <em>Healthier Lives: Diabetes</em>, an online tool with interactive heat maps demonstrating prevalence, complications, levels of care provided and the quality of care achieved for people with diabetes by local authority, clinical commissioning group and general practice. This allows local comparisons to be made against the England average as well different localities.</p><p> </p><p> </p><p> </p><p><em>Action for Diabetes</em> set out a broad vision and direction for how NHS England will support improvements in outcomes for people with and at risk of diabetes in the coming years, as a direct commissioner of services and supporting CCGs in their commissioning role. There were no recommendations specifically for CCGs to deliver.</p><p> </p> answering member constituency Battersea answering member printed Jane Ellison grouped question UIN 227502 227503 question first answered 20/03/2015 14:20:12 answering member 3918 label Biography information for Jane Ellison
tabling member	44 label Biography information for Sir David Amess

227299

registered interest
date	13/03/2015
answering body	Department of Health
answering dept id	17
answering dept short name	Health
answering dept sort name	Health
hansard heading	Diabetes
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health, what measures and indicators his Department uses to monitor and assess the quality of diabetes care.
tabling member constituency	Southend West
tabling member printed	Sir David Amess
uin	227502
answer	answer is ministerial correction date of answer 20/03/2015 answer text <p>Diabetes UK’s <em>State of the Nation</em> report called for good care for everyone with diabetes, and a greater focus on prevention. Over recent years, the quality of NHS services for people with diabetes has improved and, as a result, so have health and care outcomes.</p><p> </p><p> </p><p> </p><p>NHS England has prioritised the prevention of Type 2 diabetes. It has recently launched a programme which will make England the first country to implement at scale a national Type 2 diabetes prevention programme, modelled on our own and international proven experience. It will link into the NHS Health Check programme, which helps identify people between 40 and 75 at risk of diabetes early on so that action can be taken to prevent the disease from occurring. In the last year, almost 3 million NHS Health Check offers were made and almost 1.5 million appointments were taken up.</p><p> </p><p> </p><p> </p><p>Outcomes for people with diabetes are measured through the NHS Outcomes Framework and the Clinical Commissioning Group Outcomes Indicator Set, which are both updated and published annually. This provides clear, comparative information for clinical commissioning groups (CCGs), health and wellbeing boards, local authorities, patients and the public about the quality of health services commissioned by CCGs and the associated health outcomes. Reviewing progress against these indicators forms part of NHS England's on-going assurance of CCGs.</p><p> </p><p> </p><p> </p><p>In addition, Public Health England has produced <em>Healthier Lives: Diabetes</em>, an online tool with interactive heat maps demonstrating prevalence, complications, levels of care provided and the quality of care achieved for people with diabetes by local authority, clinical commissioning group and general practice. This allows local comparisons to be made against the England average as well different localities.</p><p> </p><p> </p><p> </p><p><em>Action for Diabetes</em> set out a broad vision and direction for how NHS England will support improvements in outcomes for people with and at risk of diabetes in the coming years, as a direct commissioner of services and supporting CCGs in their commissioning role. There were no recommendations specifically for CCGs to deliver.</p><p> </p> answering member constituency Battersea answering member printed Jane Ellison grouped question UIN 227501 227503 question first answered 20/03/2015 14:20:12 answering member 3918 label Biography information for Jane Ellison
tabling member	44 label Biography information for Sir David Amess

227302

registered interest
date	13/03/2015
answering body	Department of Health
answering dept id	17
answering dept short name	Health
answering dept sort name	Health
hansard heading	Research
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health, what amount his Department and its agencies spent on research and development in each year since 2010-11; and what proportion such spending was of total departmental spending.
tabling member constituency	Streatham
tabling member printed	Mr Chuka Umunna
uin	227561
answer	answer is ministerial correction date of answer 20/03/2015 answer text <p>Total spend by the Department and its agencies on research and development (R&amp;D) in the years 2010-11 to 2013-14 is shown in the table below.</p><p> </p><p> </p><p> </p><table><tbody><tr><td><p> </p></td><td><p>2010-11</p></td><td><p>2011-12</p></td><td><p>2012-13</p></td><td><p>2013-14</p></td></tr><tr><td><p>R&amp;D spend (£ million)</p></td><td><p>966</p></td><td><p>966</p></td><td><p>995</p></td><td><p>1,049</p></td></tr><tr><td><p>R&amp;D spend as proportion of total departmental spend (per cent)</p></td><td><p>0.9</p></td><td><p>0.9</p></td><td><p>0.9</p><p> </p></td><td><p>0.9</p></td></tr></tbody></table><p> </p><p> </p><p> </p><p> </p><p> </p> answering member constituency Mid Norfolk answering member printed George Freeman question first answered 20/03/2015 12:52:12 answering member 4020 label Biography information for George Freeman
tabling member	4128 label Biography information for Chuka Umunna

227303

registered interest
date	13/03/2015
answering body	Department of Health
answering dept id	17
answering dept short name	Health
answering dept sort name	Health
hansard heading	Brain Cancer
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health, what assessment he has made of the effect of a ketogenic diet in treating brain cancer patients.
tabling member constituency	Windsor
tabling member printed	Adam Afriyie
uin	227519
answer	answer is ministerial correction date of answer 20/03/2015 answer text <p>No such assessment has been made.</p><p> </p> answering member constituency Battersea answering member printed Jane Ellison question first answered 20/03/2015 14:15:26 answering member 3918 label Biography information for Jane Ellison
tabling member	1586 label Biography information for Adam Afriyie

227304

registered interest
date	13/03/2015
answering body	Department of Health
answering dept id	17
answering dept short name	Health
answering dept sort name	Health
hansard heading	Epilepsy
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health, what steps he has taken to reduce waiting times for urgent referrals of epilepsy patients.
tabling member constituency	Barnsley Central
tabling member printed	Dan Jarvis
uin	227574
answer	answer is ministerial correction date of answer 18/03/2015 answer text <p>The National Institute for Health and Care Excellence (NICE) guidance <em>The diagnosis and management of the epilepsies in adults and children in primary and secondary care</em> published in January 2012 sets out best practice for clinicians on the diagnosis, treatment, care and support of people with epilepsy. The NICE guidance recommends that people having a first seizure should be seen as soon as possible by a specialist, with patients being seen within two weeks if possible.</p><p> </p><p> </p><p> </p><p>Local organisations should consider NICE guidance when planning services for resident populations. We expect patients to receive the most clinically appropriate care at the right time in the most appropriate setting. Clinical priority is, and remains, the main determinant of when patients should be seen or treated as appropriate.</p><p> </p> answering member constituency North Norfolk answering member printed Norman Lamb question first answered 18/03/2015 17:17:46 answering member 1439 label Biography information for Norman Lamb
tabling member	4243 label Biography information for Dan Jarvis

227305

registered interest
date	13/03/2015
answering body	Department of Health
answering dept id	17
answering dept short name	Health
answering dept sort name	Health
hansard heading	Health Services: Technology
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health, what technologies are being developed with support from the Small Business Research Initiative programmes of (a) his Department and (b) NHS England; and what assessment he has made of the future potential uses of those technologies.
tabling member constituency	Streatham
tabling member printed	Mr Chuka Umunna
uin	227523
answer	answer is ministerial correction date of answer 20/03/2015 answer text <p>The Department, through the Small Business Research Initiative (SBRI), is currently funding the development of a number of technologies aimed at promoting patient empowerment and sustainability in kidney care. Six phase 2 SBRI contracts valued at £2 million were awarded in February 2015. The technologies being developed range from diagnostics to digital solutions, for use in the home and in secondary care. Potential uses include early infection detection in patients on peritoneal dialysis, prevention of acute kidney injury and renal patient transport.</p><p> </p><p> </p><p> </p><p>The Department is also supporting, through SBRI, the development of enabling technologies for genomics sequence data analysis and interpretation. In March 2015 five phase 2 SBRI contracts, valued at £8 million, were awarded for the development of next generation sequencing technologies which were assessed as having the potential to help deliver the Prime Minister’s 100,000 Genome Project. Potential uses are in the areas of diagnostics related to genome screening, clinical research, gene-discovery and wider use of stratified medicine. The technologies are hoped to provide more accurate variant calling and annotation pipelines, new ways of expressing the reference genomes, improving human leukocyte antigen genotyping and intuitive user interfaces to allow clinicians to interpret variants from next generation sequencing machines.</p><p> </p><p> </p><p> </p><p>The NHS England SBRI Healthcare programme currently has 138 contracts with companies to develop innovative technologies to address known healthcare needs. These range from diagnostics to digital management solutions; embracing conditions such as cancer, chronic obstructive pulmonary disease, cardiovascular disease, diabetes, dementia and patient safety and bringing solutions for mental health, primary and acute care. Assessment of the programme by the Office of Health Economics and the SBRI Healthcare team in 2014 has shown that since 2012 the pipeline has a potential to secure £434 million efficiency savings each year for the next decade. Assessment of the programme also shows that 150 jobs have been created, 31 patents awarded and over £10 million of additional investment has been leveraged.</p><p> </p><p> </p><p> </p><p>The technologies supported include a light therapy sleep mask for the prevention of diabetic retinopathy; ultraviolet scope enabling intraoperative visibility of cancer cells in surgery; a point of care cardiac diagnostic to fully diagnose a heart attack within 20 minutes and a blood test to definitively rule out a diagnosis of colorectal cancer.</p><p> </p> answering member constituency Battersea answering member printed Jane Ellison question first answered 20/03/2015 14:35:19 answering member 3918 label Biography information for Jane Ellison
tabling member	4128 label Biography information for Chuka Umunna

227334

registered interest
date	13/03/2015
answering body	Department of Health
answering dept id	17
answering dept short name	Health
answering dept sort name	Health
hansard heading	National Institute for Health and Care Excellence
house id	2
legislature	25277 pref label House of Lords
question text	To ask Her Majesty’s Government what assessment they have made of the extent to which the National Institute for Health and Care Excellence is promoting innovation in the provision of health and social care as required by the Health and Social Care Act 2012.
tabling member printed	Lord Hunt of Kings Heath
uin	HL5721
answer	answer is ministerial correction date of answer 23/03/2015 answer text <p>The National Institute for Health and Care Excellence (NICE) plays an important role in promoting innovation in the health and care system through the development of authoritative, evidence-based guidance on the most effective and cost-effective ways to prevent and treat ill health, and through the dissemination of information on innovative new technologies. For example, in the development of its technology appraisal guidance and Highly Specialised Technologies guidance, NICE ensures that the benefits to patients from an innovative technology are fully captured in its decision-making. NICE also disseminates information on innovative new drugs and other technologies through tailored briefings for the health and care system.</p><p> </p> answering member printed Earl Howe question first answered 23/03/2015 13:55:28 answering member 2000 label Biography information for Earl Howe
tabling member	2024 label Biography information for Lord Hunt of Kings Heath

227344

registered interest
date	13/03/2015
answering body	Department of Health
answering dept id	17
answering dept short name	Health
answering dept sort name	Health
hansard heading	Meningitis: Vaccination
house id	2
legislature	25277 pref label House of Lords
question text	To ask Her Majesty’s Government what discussions they have had with the manufacturers of the Meningitis B vaccine Bexsero on behalf of all health departments within the United Kingdom.
tabling member printed	Lord Empey
uin	HL5731
answer	answer is ministerial correction date of answer 26/03/2015 answer text <p>We have had a number of meetings with the manufacturer for supply of the meningococcal B vaccine, Bexsero<sup>®</sup> at a cost-effective price, as recommended by the Joint Committee on Vaccination and Immunisation, and we are continuing to meet.<br> <br></p><p> </p><p>The Department is conducting these negotiations on behalf of the devolved administrations, as is usual and agreed practice.</p><p> </p> answering member printed Earl Howe grouped question UIN HL5732 HL5733 question first answered 26/03/2015 12:42:50 answering member 2000 label Biography information for Earl Howe
tabling member	4216 label Biography information for Lord Empey